REMINE

According to recent studies, Risks Against Patient Safety (RAPS) represent one of the most important factors of dead in hospitals: during therapy, more then 8% of patients recovered in hospitals suffer for additional disease that in almost 50% of the cases produce either dead or significant additional health problems. RAPS occur in any stage of the patient care process.

REMINE project idea originates from the common difficulty in conducting a analysis, early identification and effective prevention on RAP when there are significant mass of inhomogeneous data sources, stored in multimedia databases, and a distributed environments with different care professionals contemporary involved.

To contrast the RAPS trends and the malpractices diffusion, REMINE prosecutes a number of main objectives. a new technological platform, new care process organizational requirements. Main elements are: mining of multimedia data; modelling, prediction, detection of RAPS, RAPS management support system and info broker patient safety framework.

Main outcomes of REMINE will be: time reduction in collecting data, time reduction in RAPS analysis, standardization of common language, evolution in the interaction model, reference framework, patient safety improvement, health care cost saving (within an estimated RAPS reduction between 6% to 9% of RAPS.

For further information, please visit:
http://www.remine-project.eu

Project co-ordinator:
GMD - Gesellschaft für Medizinische Datenverarbeitung mbH

Partners:

  • INFO WORLD S.R.L. (Romania)
  • CONSORZIO PER L'INNOVAZIONE NELLA GESTIONE DELLE IMPRESE E DELLA PUBBLICA AMMINISTRAZIONE DENOMINATO ANCHE MIP (Italy)
  • The Rotherham Foundation Trust (United Kingdom)
  • Research in Advanced Medical Informatics and Telematics (Belgium)
  • Technische Universität Wien (Austria)
  • SEK-Suupohjan elinkeinotoimen kuntayhtymä (Finland)
  • SOLUZIONA, S.A. (Slovenia)
  • The Institute of Communications and Computer Systems (Greece)
  • QUALITY AND SYSTEMS CONSULTING LTD (United Kingdom)
  • QUALITY & RELIABILITY A.E. (Greece)
  • Aminio AB (Sweden)
  • Link Consulting - Tecnologias de Informacao S.A. (Portugal)
  • Hewlett-Packard Italiana Srl (Italy)
  • Regione Lombardia (Italy)

Timetable: from 01/2008 - to 12/2010

Total cost: € 7.728.249

EC funding: € 5.400.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...